Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Seattle Genetics, Amicus plunge; AVI, DepoMed rally
Marketwatch
Monday, October 5, 2009 - 3:03pm
tags:
Seattle Genetics, Amicus Therapeutics, AVI BioPharma, biotech
FDA panel narrowly backs Schering-Plough's PegIntron as a skin cancer medication
Yahoo/AP
Monday, October 5, 2009 - 3:00pm
tags:
FDA, Schering Plough, skin cancer, PegIntron
Allergan Insists DOJ Subpoena and Lawsuit v. FDA on Botox Are Unlinked
BNET Pharma
Monday, October 5, 2009 - 11:43am
tags:
Allergan, Botox, DOJ, off-label, FDA
AstraZeneca chief executive will call on the US Government to give the Food and Drug Administration ‘a full set of teeth’
Times Online, UK
Monday, October 5, 2009 - 11:43am
tags:
AstraZeneca, FDA, Pharma CEOs, David Brennan
EU approves AstraZeneca, Bristol diabetes drug
Marketwatch
Monday, October 5, 2009 - 11:21am
tags:
AstraZeneca, Bristol-Myers Squibb, Europe, diabetes, Onglyza
CombinatoRx shares pop on Fovea news
Bizjournals.com
Monday, October 5, 2009 - 11:19am
tags:
CombinatoRx, Fovea, Sanofi
Fortunes Being Made in Small-Cap Pharmaceutical Stocks
Yahoo/Indie Research
Monday, October 5, 2009 - 10:58am
tags:
Neuralstem, Depomed, MannKind, AVI BioPharma, Osiris Therapeutics, Opexa
Allos Therapeutics' cancer drug Folotyn now for sale
Bizjournals.com
Monday, October 5, 2009 - 10:57am
tags:
Allos, Folotyn, cancer
Struggling Trimeris gets snapped up for $81M
Fierce Biotech
Monday, October 5, 2009 - 10:54am
tags:
Trimeris, M&A, South Korea, Arigene, Fuzeon
Seattle Genetics Halts Lymphoma Drug Study
TheStreet.com
Monday, October 5, 2009 - 10:51am
tags:
Seattle Genetics, lymphoma, drug studies, dacetuzumab, non-Hodgkin's lymphoma
Sandoz Plans to Sell More Drugs in Japan, May Acquire Companies
Bloomberg
Monday, October 5, 2009 - 10:50am
tags:
Sandoz, generics, Japan, Novartis
Lucentis improves sight after 7 days in 2 studies
Reuters
Monday, October 5, 2009 - 10:48am
tags:
Lucentis, Genentech, RVO, retinal vein occlusion, Roche
5 Biotech Stocks to Keep an Eye On
Seeking Alpha
Monday, October 5, 2009 - 10:46am
tags:
biotech, Human Genome Sciences, Cel-Sci, AVI BioPharma, Invovio, Oncolytics
Cel-Sci May Be in for a Bumpy Ride This Week
Seeking Alpha
Monday, October 5, 2009 - 10:45am
tags:
Cel-Sci
Resverlogix: The Canadian Biotech Blockbuster
Minyanville
Monday, October 5, 2009 - 10:36am
tags:
Resverlogix, Canada, Alzheimer's disease
Sanofi to Sell Its Own Generic Version of Plavix, La Lettre Says
Bloomberg
Monday, October 5, 2009 - 10:35am
tags:
Plavix, Sanofi, generics, Winthrop Pharmaceuticals
Boehringer Sees ‘Uphill Battle’ With Merck, Astra in Diabetes
Bloomberg
Monday, October 5, 2009 - 10:32am
tags:
Boehringer Ingelheim, diabetes, Merck, AstraZeneca, linagliptin
Glaxo reports positive Phase 2 PHN drug study
Marketwatch
Monday, October 5, 2009 - 10:24am
tags:
GSK, neuropathic pain, drug studies
As TV Drug Ads Increase, So Do Concerns
MSN
Sunday, October 4, 2009 - 11:34am
tags:
drug ads
Capital Markets Open Up to Biotechs
Seeking Alpha
Sunday, October 4, 2009 - 11:32am
tags:
biotech

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.